Zai Lab Ltd (ZLAB) stock
ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30421% above fair value
$23.53+0.06 (+0.26%)
Close on Nov 17, 2026Market cap $3.65BP/E –Yield –
Zai Lab price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Zai Lab's price to book ratio was 4.9× on Nov 11, 2026, against 3.0× a year earlier. Over the last 5 years it ranged from 1.8× to 5.1×, with a median of 3.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.9× | +2.3 |
| 2025 | Dec 31, 2025 | 2.6× | −1.3 |
| 2024 | Dec 31, 2024 | 3.9× | +0.9 |
| 2023 | Dec 29, 2023 | 3.0× | +0.3 |
| 2022 | Dec 30, 2022 | 2.7× | −1.1 |
| 2021 | Dec 31, 2021 | 3.8× | −18.0 |
| 2020 | Dec 31, 2020 | 21.8× | +13.4 |
| 2019 | Dec 31, 2019 | 8.4× | +3.4 |
| 2018 | Dec 31, 2018 | 4.9× | – |
See a number that looks wrong?